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Objective: There is much interest in the role of dietary protein for weight control. However, there remains
a need to characterize individual determinants of the thermogenic effects of protein. This study aimed to
investigate the influence of menstrual cycle phase and the combined, monophasic oral contraceptive pill
on the thermogenic response to a standardized high-protein (HP) versus normal-protein (NP) meal.
Methods: Following an overnight fast, resting energy expenditure (EE) was measured in 16 healthy young
women (8 taking and 8 not taking the pill) and 8 men for 30 minutes pre ingestion and 3 hours post
ingestion of a NP (11%) or HP (24%) meal.
Results: There was no effect of menstrual phase or contraceptive pill use on fasting EE or NP response.
However, HP increased EE significantly more than NP in women not taking the oral contraceptive pill and
in men, but not in women taking the pill.
Conclusions: This study shows an absence of the greater thermic effect of HP versus NP in women tak-
ing the oral contraceptive pill and has important implications regarding the effectiveness of HP for body
weight regulation in women. With current obesity treatment/prevention strategies remaining largely inef-
fective, understanding the relationship between oral contraceptive pill use and protein-induced thermo-
genesis may enable the successful recalibration of existing dietary recommendations.
Introduction
Although men and women share the same environmental risk factors,
the prevalence of obesity in women now exceeds that of men in all
World Bank regions (1,2). The concomitant surge in obesity-related
cardiometabolic disease (type 2 diabetes, cardiovascular disease) in
women of childbearing age is a growing public health burden, not
only for women’s health but also for the health of future children
through epigenetic modification. However, existing diet intervention
strategies make little or no distinction between the sexes. This “one-
size-fits-all” approach is ineffective, with women generally losing less
weight during such interventions than men (3).
Successful approaches to weight control should elicit effects on both
sides of the energy balance equation, i.e., energy intake and energy
expenditure (EE). For this reason, there has been much interest in
the role of dietary protein, which has been demonstrated to favor-
ably affect satiety (4), thermogenesis (5,6), body weight (7), and
body composition (8). However, there have been a number of dis-
crepancies in study findings (9), and as such, there is a need to char-
acterize individual determinants of the thermogenic and satiety
effects of dietary protein.
Toward this end, the goal of the present study was to determine the
influence of menstrual cycle phase and oral contraceptive use on the
thermogenic response to a standardized high-protein (HP) meal in
healthy young women.
Methods
Participant recruitment and screening
Sixteen healthy young women of European descent participated in
the present study, with a mean (6 SEM) age of 236 1 years, weight
of 61.26 2.7 kg, fat-free mass (FFM) of 46.36 0.9 kg, and BMI of
22.06 0.7 kg/m2. A group of eight healthy young men (age 236 1
years, weight 67.36 2.2 kg, FFM 61.26 2.5 kg, and BMI 21.26
0.6 kg/m2) was recruited to act as a time control. Prior to testing,
participants visited the laboratory in order to complete a question-
naire regarding their lifestyle and medical history and to familiarize
themselves with the experimental procedure and equipment. All par-
ticipants were weight stable. Smokers, claustrophobic individuals,
individuals taking medication other than the oral contraceptive pill,
and those with any metabolic disease or food intolerance were
excluded. The female participants were split evenly between eight
women not taking the oral contraceptive pill (age 246 1 years,
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weight 60.66 2.1 kg, FFM 45.86 1.0 kg, and BMI 22.06 0.6 kg/m2)
and eight women regularly taking a combined, monophasic oral con-
traceptive containing 20 to 35lg (median: 25lg, mode: 20lg) of
ethinyl estradiol (age 236 1 years, weight 61.86 5.1 kg, FFM
46.86 1.5 kg, and BMI 21.96 1.2 kg/m2). Each participant com-
pleted four separate experimental test visits. In women, two of these
visits occurred during the follicular phase of the menstrual cycle
(approximate cycle day 5-12, with cycle day 1 determined by self-
report), and the other two visits occurred during the luteal phase
(approximate cycle day 19-26). This timing was matched in the
men, with the second two visits (control phase 2 [C2]) occurring 2
weeks after the first two visits (control phase 1 [C1]). In both men
and women, experimental visits were separated by an interval of at
least 2 days. The study complied with the Declaration of Helsinki
and was approved by the state ethical review board; all participants
gave written consent.
Experimental design
On the day of testing, participants arrived at the laboratory at 8:00
AM following a 12-hour overnight fast. Body composition was deter-
mined using multifrequency bioimpedance analysis (InBody 720,
Biospace Co., Ltd., Seoul, Korea). EE was measured using a venti-
lated hood system (Quark CPET, COSMED, Rome, Italy). Briefly,
participants were seated comfortably in a car seat adapted for calori-
metric monitoring (10-12), with metabolic measurement conducted
for at least 30 minutes, after 15 minutes of rest. The ventilated hood
was then removed while the subject ingested one of the two test
meals described below within a 10-minute period. The ventilated
hood was replaced, and calorimetric monitoring was continued for a
further 180 minutes. Participants were permitted to watch a calm
movie or a documentary during the metabolic measurements.
Test meals
Two isocaloric 590 kcal test meals were used in this study, differing
in protein as a percentage of total energy. The composition of these
meals is shown in Table 1. Each meal consisted of a simple break-
fast meal base (two slices of toast and a 200mL milk-based drink
[Nestle Resource, Nestle Health Science, Florham Park, New Jer-
sey]) to which protein powder (Protifar, Nutricia, Schiphol, the
Netherlands), butter, and jam were added to adjust the protein con-
tent as necessary while maintaining the ratio of carbohydrate to fat
as a constant at 1.41. Both test meals were given during both the
follicular and luteal phases in women and during control phases C1
and C2 in men. The order of the test meals was randomized between
normal-protein (NP) and HP meals, and the participants were
blinded to the meal order.
Data and statistical analysis
Minute-by-minute values of the metabolic recordings were averaged
in 30-minute intervals for both the baseline and 3-hour postprandial
period. All data are presented as mean6 SEM. The statistical treat-
ment of data, by repeated-measures analysis of variance (ANOVA)
or three-factor ANOVA (pill, menstrual cycle phase, meal protein
level) followed by post hoc multiple comparison tests, was per-
formed using the computer software Statistix 8 (Analytical Software,
St Paul, Minnesota).
Results
As shown in Figure 1, there was no effect of either menstrual cycle
phase (P5 0.6) or oral contraceptive use (P5 0.6) on baseline
(fasted) resting EE in women, and there was no effect of time on
baseline (fasted) resting EE in men (i.e., no difference between con-
trol phases C1 and C2; P5 0.6).
Following ingestion of the NP test meal, EE increased significantly
from baseline (P< 0.001) in women both taking and not taking the oral
contraceptive pill and in men, and there was no effect of menstrual
cycle phase in either group of women (P5 0.13; Figure 2) and no time
effect in men (i.e., control phase C1 vs. control phase C2; P5 0.4).
However, while ingestion of the HP test meal further increased rest-
ing (postprandial) EE beyond the level of the NP diet in women not
taking the oral contraceptive pill (P< 0.001; Figure 2A) and in men
(P< 0.001; Figure 2C), no such increase in EE was observed in
women taking the pill (P5 0.14; Figure 2B). This lack of potentia-
tion in EE can also be observed in the calculated 3-hour thermic
effect of each test meal (Figure 2D-2F). A three-factor ANOVA,
with pill, meal protein level, and menstrual cycle phase as main
TABLE 1 Meal composition
Energy (kcal) Energy (%)
Ratio
Protein CHO Fat Total Protein CHO Fat CHO:Fat
NP 62 308 219 589 11 52 37 1.41
HP 142 261 186 589 24 44 32 1.41
CHO, carbohydrate; HP, high protein; NP, normal protein.
Figure 1 Baseline (fasted) resting energy expenditure (EE). EE according to com-
bined, monophasic oral contraceptive pill use (n5 8 per group) and menstrual cycle
phase (follicular [F] vs. luteal [L]) in young women. Values for men are shown on
the right, with C1 referring to the first control phase and C2 to the second control
phase (i.e., the retest after a 2-week interval). Mean6SEM for normal protein (NP):
baseline EE prior to ingestion of a NP meal; mean6SEM for high protein (HP):
baseline prior to the ingestion of a HP meal; ns: no statistically significant difference








factors, revealed a significant pill and meal protein level interaction
(P< 0.005). A subgroup analysis of women taking the pill (i.e.,
women taking 20lg/d [n5 4] compared to those taking 30-35 lg/d
[n5 4]) found no relationship between ethinyl estradiol dosage and
the EE response to the NP versus HP meal in either cycle phase.
Discussion
Young women, particularly those of childbearing age, are developing
obesity and its related comorbidities at a rapidly increasing rate com-
pared with men of the same age (see, for example, Ford, Giles, and
Figure 2 Change in resting energy expenditure (EE) following ingestion of an isocaloric meal containing
either normal protein (NP; 11% of total energy) or high protein (HP; 24% of total energy). (A) Women not
taking the combined, monophasic oral contraceptive pill. Mean6SEM; repeated-measures ANOVA (effect
of meal): P< 0.001; F, follicular phase; L, luteal phase. (B) Women regularly taking the combined oral
contraceptive pill. Mean6SEM; repeated-measures ANOVA (effect of meal): P5 0.14. (C) Men. Mean6
SEM; repeated-measures ANOVA (effect of meal): P< 0.001; control phase 1, C1; control phase 2, C2.
(D-F) Area-under-curve (i.e., thermic effect [kilocalories per 3 hours]); mean6SEM; statistical significance








Mokdad (1)). Furthermore, it appears that current diet intervention
strategies to treat and prevent obesity are largely ineffective (13), par-
ticularly in women (3). In this context, there is a considerable need to
investigate the sources of interindividual variability in our metabolic
responses to dietary modification. Dietary protein may provide an
important tool to facilitate weight control through increased satiety
and thermogenesis. However, in the present study, we observed an
abolishment of the greater thermic effect of a HP versus NP meal in
women taking the combined, monophasic oral contraceptive pill.
As no effect of menstrual cycle phase on the acute thermic response to
dietary protein was observed, no significant differences were found in
body composition between women taking and women not taking the
oral contraceptive pill, and as women not taking the oral contraceptive
pill responded comparably to men, these results indicated an effect of
exogenous rather than endogenous sex hormones (estrogen and pro-
gesterone). However, whether this effect resides in the digestive and
absorptive processes or in the protein metabolism itself (e.g., the rate
of protein turnover) remains to be determined. The combined oral con-
traceptive pill has previously been associated with an increased gut
transit time (14), decreased absorption of a variety of vitamins and
minerals (15,16), and decreased serum albumin levels (15). It has been
found, as well, to increase both endogenous creatinine clearance and
the nitrogen excretion rate/daily protein intake ratio (17) and to inhibit
myofibrillar protein synthesis (18).
Regardless of the underlying mechanism(s), given that 9% of the
world’s women aged between 15 and 49 who are married or living
with a partner are using the contraceptive pill (and given usage as high
as 37.5% in Western Europe) (19), this finding has important implica-
tions for the effective use of HP for body weight regulation in women.
With current “one-size-fits-all” obesity treatment and prevention strat-
egies being generally ineffective, understanding the relationship
between sex hormone status and our metabolic responses to dietary
factors, such as protein intake, is key to enabling the successful recali-
bration of existing diet/lifestyle recommendations.O
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